Literature DB >> 28947944

Anchimerically Activatable Antiviral ProTides.

Aniekan Okon1, Marcos Romário Matos de Souza2, Rachit Shah1, Raquel Amorim2, Luciana Jesus da Costa2, Carston R Wagner1,1.   

Abstract

This work describes the synthesis and biological evaluation of an anchimerically activated proTide of 2'-C-β-methylguanosine as an inhibitor of dengue virus 2 (DENV-2). The proTide incorporates a chemically cleavable 2-(methylthio)ethyl moiety and a HINT1 hydrolyzable tryptamine phosphoramidate. Inhibition of DENV-2 replication by proTide 6 was 5-fold greater than the parent nucleoside while displaying no apparent cytotoxicity. Furthermore, we demonstrate with a HINT1 inhibitor that the anti DENV-2 activity of the proTide correlates with the activity of HINT1. Taken together, these results demonstrate that a phosphoramidate based pronucleotide that undergoes an initial nonenzymatic activation step based on anchimeric assistance followed by P-N bond cleavage by HINT1 can be prepared.

Entities:  

Keywords:  Dengue virus; Phosphoramidate; antiviral; pronucleotide

Year:  2017        PMID: 28947944      PMCID: PMC5601376          DOI: 10.1021/acsmedchemlett.7b00277

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

1.  cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.

Authors:  C Meier; T Knispel; E De Clercq; J Balzarini
Journal:  J Med Chem       Date:  1999-05-06       Impact factor: 7.446

2.  Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.

Authors:  Christopher McGuigan; Arnaud Gilles; Karolina Madela; Mohamed Aljarah; Sabrina Holl; Sarah Jones; John Vernachio; Jeff Hutchins; Brenda Ames; K Dawn Bryant; Elena Gorovits; Babita Ganguly; Damound Hunley; Andrea Hall; Alexander Kolykhalov; Yule Liu; Jerry Muhammad; Nicholas Raja; Robin Walters; Jin Wang; Stanley Chamberlain; Geoffrey Henson
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

3.  Comparative analysis of esterase activities of human, mouse, and rat blood.

Authors:  E V Rudakova; N P Boltneva; G F Makhaeva
Journal:  Bull Exp Biol Med       Date:  2011-11       Impact factor: 0.804

4.  Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases.

Authors:  T Minagawa; Y Kohno; T Suwa; A Tsuji
Journal:  Biochem Pharmacol       Date:  1995-05-17       Impact factor: 5.858

Review 5.  Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences.

Authors:  E V Koonin; V V Dolja
Journal:  Crit Rev Biochem Mol Biol       Date:  1993       Impact factor: 8.250

6.  Efficient synthesis of 2'-C-beta-methylguanosine.

Authors:  Nan-Sheng Li; Joseph A Piccirilli
Journal:  J Org Chem       Date:  2006-05-12       Impact factor: 4.354

Review 7.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

8.  The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.

Authors:  Christopher McGuigan; Plinio Perrone; Karolina Madela; Johan Neyts
Journal:  Bioorg Med Chem Lett       Date:  2009-06-10       Impact factor: 2.823

Review 9.  Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus.

Authors:  Bryant B Summers; Joshua W F Beavers; Olga M Klibanov
Journal:  J Pharm Pharmacol       Date:  2014-08-31       Impact factor: 3.765

10.  Transforming Growth Factor-β1 Induced Epithelial Mesenchymal Transition is blocked by a chemical antagonist of translation factor eIF4E.

Authors:  K A Smith; B Zhou; S Avdulov; A Benyumov; M Peterson; Y Liu; A Okon; P Hergert; J Braziunas; C R Wagner; Z Borok; P B Bitterman
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

View more
  4 in total

1.  A Phosphoramidate Strategy Enables Membrane Permeability of a Non-nucleotide Inhibitor of the Prolyl Isomerase Pin1.

Authors:  Daniel M C Schwarz; Sarah K Williams; Maxwell Dillenburg; Carston R Wagner; Jason E Gestwicki
Journal:  ACS Med Chem Lett       Date:  2020-08-10       Impact factor: 4.345

2.  4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.

Authors:  Blake A Jacobson; Zeeshan Ahmad; Sierra Chen; Gabriella Waldusky; Maxwell Dillenburg; Emilia Stoian; Daniel A Cambron; Anil J Patel; Manish R Patel; Carston R Wagner; Robert A Kratzke
Journal:  Invest New Drugs       Date:  2020-11-23       Impact factor: 3.850

Review 3.  In vitro methods for testing antiviral drugs.

Authors:  Michaela Rumlová; Tomáš Ruml
Journal:  Biotechnol Adv       Date:  2017-12-29       Impact factor: 14.227

Review 4.  Opening up the Toolbox: Synthesis and Mechanisms of Phosphoramidates.

Authors:  Emeka J Itumoh; Shailja Data; Erin M Leitao
Journal:  Molecules       Date:  2020-08-13       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.